TGF-β acts as a tumor-promoting cytokine by stimulating cancer cell migration and invasion, extracellular matrix remodeling, epithelial-to-mesenchymal transition (EMT), and the induction of an immunosuppressive TME (16). The gene discussed is TGFB1; the disease is cancer.